# About CJC-1295 Legit — Independent Editorial Project > About CJC-1295 Legit: an independent editorial project that summarizes peer-reviewed research and the regulatory record on CJC-1295. Editorial standards, sourcing methodology, and disclaimer. An independent editorial project, not a clinic, not a vendor, not a regulatory authority. ## What this site is CJC-1295 Legit is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295 (DAC:GRF, the long-acting GHRH analog developed by ConjuChem Biotechnologies). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science. The site covers the compound's mechanism of action, the published human and animal studies, the anti-doping and forensic analytical literature, and the regulatory record — including the FDA PCAC December 2024 proceedings, the 503A compounding status, and the WADA prohibition. We do not advocate for or against any use of CJC-1295. Our editorial position is that the research record and regulatory record deserve accurate representation, presented in plain language, without agenda. The name 'Legit' reflects the editorial frame: a calm, honest reading of what the record actually says, without marketing varnish and without alarmism. The 'legit' modifier does not mean we verify any product, supplier, or clinical use. It means we try to represent the documented facts of the scientific and regulatory record accurately. ## Editorial standards Every quantitative claim on this site — dose values, half-life numbers, study participant counts, statistical results — is traced to a specific published study from our research corpus we compiled. Where a claim is specific (for example, '5.8–8.1 days'), the source is identified by an inline citation number that links to the full reference on the /references page. We use three classes of sources: - **Primary research**: randomized controlled trials, pharmacokinetic studies, animal model experiments, proteomic analyses, forensic analytical studies. These are treated as the highest-quality evidence and cited directly wherever they are the original source of a claim. - **Review articles**: systematic reviews, meta-analyses, and narrative reviews from peer-reviewed journals. Cited to provide context and to characterize the field's collective interpretation, not as original data. - **Regulatory and policy documents**: FDA advisory committee briefing documents, WADA Prohibited List text, agency Federal Register notices, and secondary policy analyses from authoritative legal sources. These are cited for the regulatory record — what agencies have decided or documented — and not treated as evidence of scientific fact. We do not invent research. If a claim is not in our source material, we do not write it. We do not extrapolate animal findings to human clinical outcomes. We do not endorse or speculate about products, doses, or protocols outside the published literature. ## Disclaimer and limitations Nothing on this site constitutes medical advice, clinical guidance, or dosing recommendations. The research summarized here was conducted in controlled settings by qualified investigators. This site does not suggest that any person attempt to replicate any research protocol. The regulatory status of CJC-1295 is complex and evolving. This site describes the documented regulatory record as of mid-2026; readers with specific regulatory questions should consult qualified legal counsel or the relevant agency. The record may change as FDA proceedings progress. The 'Legit' domain modifier is editorial framing that positions this site relative to its topic — a calm, honest reading of the research and regulatory record. It is not a claim about services offered, clinical staff employed, or products sold. This is an independent editorial research digest, not a clinic, not a vendor, and not a regulatory authority. No reasonable reading of this site's content implies treatment, consultation, or prescription services. --- A research digest of peer-reviewed literature and the regulatory record — not a clinic, not a vendor, not medical advice.